![]() | Only 14 pages are availabe for public view |
Abstract The use Of HA as an orbital improvant to improve motirily was devised by Mhur Perry, and its use in the orbit was approved by the FDA in August 1989Y~) The ideal oCl.llar implant should be completely buried: simple in construction without projecting or angulaled surfaces thai might erode though lIle conjunctiva, rightweight, and smaller than the globe 10 aljQ\.\1for prosthesis Of adequate anterior chamber depth. ln aodltion, il should be ~nlered within the muscle cone, and anchored to orbital tissues to minimize extrusion II should have extra-ocular muscles attached, and should be directly integrated in some way with the prosthesis for 1:1 transfer of motility. It should induce minimal tissue inflammalion and should nat resorb over time. HA implanted as described above fulfills all of these criteria Clin~cal trials over the pas I several years, proved that the technique 10be safe and effective(74J, With no significant complications~78:’ Coreilina HA as an ocular implanl appears to offer.a significant improvement aver all previously used material’S. However, the cost ot the implant, represents a major obstacle in the reconstructive process. That is why. we Ined ill this study, 10 test another implant material {5ynthetic HA}, that is half-priced the price of Coralline HA. There were a number of indications 10 proceed with the reconstructive technique of ocular implant that included atrophic globes, blind·painful eyas, severely traumatized globes, endapnlhalmitis, and intra-ocular rnaliqnancy. |